11168137

Source:http://linkedlifedata.com/resource/pubmed/id/11168137

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004623, umls-concept:C0008777, umls-concept:C0020933, umls-concept:C0021708, umls-concept:C0066005, umls-concept:C1880496
pubmed:issue	6
pubmed:dateCreated	2001-3-6
pubmed:abstractText	To compare the efficacy and tolerability of meropenem and imipenem/cilastatin as empirical monotherapy in intensive care unit (ICU) patients with serious bacterial infections.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9516420
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cilastatin, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Imipenem, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Thienamycins, http://linkedlifedata.com/resource/pubmed/chemical/meropenem
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1198-743X
pubmed:author	pubmed-author:Belgian Multicenter Study Group, pubmed-author:VerwaestCC
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	294-302
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11168137-Adult, pubmed-meshheading:11168137-Aged, pubmed-meshheading:11168137-Aged, 80 and over, pubmed-meshheading:11168137-Bacterial Infections, pubmed-meshheading:11168137-Belgium, pubmed-meshheading:11168137-Cilastatin, pubmed-meshheading:11168137-Drug Combinations, pubmed-meshheading:11168137-Female, pubmed-meshheading:11168137-Gram-Negative Bacteria, pubmed-meshheading:11168137-Gram-Positive Bacteria, pubmed-meshheading:11168137-Humans, pubmed-meshheading:11168137-Imipenem, pubmed-meshheading:11168137-Infusions, Intravenous, pubmed-meshheading:11168137-Intensive Care Units, pubmed-meshheading:11168137-Male, pubmed-meshheading:11168137-Middle Aged, pubmed-meshheading:11168137-Protease Inhibitors, pubmed-meshheading:11168137-Thienamycins, pubmed-meshheading:11168137-Treatment Outcome
pubmed:year	2000
pubmed:articleTitle	Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit.
pubmed:affiliation	Department of Intensive Care Medicine, University Hospital Gasthuisberg, Leuven, Belgium. Charles.Verwaest@uz.kuleuven.ac.be
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study